Effect of Hydroxychloroquine in Hospitalized Patients with Covid-19
Author(s) -
Peter Horby,
Marion Mafham,
Louise Linsell,
Jennifer Bell,
Natalie Staplin,
Jonathan Emberson,
Martin Wiselka,
Andrew Ustianowski,
Einas Elmahi,
Benjamin Prudon,
Tony Whitehouse,
Timothy Felton,
John Williams,
Jakki Faccenda,
Jonathan Underwood,
J. Kenneth Baillie,
Lucy C. Chappell,
Saul N. Faust,
Thomas Jaki,
Katie Jeffery,
Wei Shen Lim,
Alan Montgomery,
Kathryn Rowan,
Joel Tärning,
James A Watson,
Nicholas J White,
Edmund Juszczak,
Richard Haynes,
Martin Landray
Publication year - 2020
Publication title -
new england journal of medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 19.889
H-Index - 1030
eISSN - 1533-4406
pISSN - 0028-4793
DOI - 10.1056/nejmoa2022926
Subject(s) - hydroxychloroquine , covid-19 , chloroquine , medicine , randomized controlled trial , coronavirus , virology , disease , pathology , infectious disease (medical specialty) , outbreak , malaria
Hydroxychloroquine and chloroquine have been proposed as treatments for coronavirus disease 2019 (Covid-19) on the basis of in vitro activity and data from uncontrolled studies and small, randomized trials.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom